Doctors who take company cash are more likely to prescribe brand name drugs, analysis findsBMJ 2016; 352 doi: https://doi.org/10.1136/bmj.i1645 (Published 21 March 2016) Cite this as: BMJ 2016;352:i1645
- Michael McCarthy
An analysis by the independent investigative news organization ProPublica has found that doctors who accept gifts or receive payments from the medical industry tend to prescribe more brand name drugs than doctors who do not accept such benefits.1
In the study, ProPublica reporters matched records of payments from drug companies and medical device makers in 2014 with data on doctors’ medication choices in Medicare’s prescription drug program, Medicare Part D, which covers more than 39 million patients. The analysis looked at doctors in five specialties (family medicine, internal medicine, cardiology, psychiatry, and ophthalmology) who wrote at least …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial